These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 17226745)

  • 1. Dementia and neurocognitive disorders due to HIV-1 infection.
    Ances BM; Ellis RJ
    Semin Neurol; 2007 Feb; 27(1):86-92. PubMed ID: 17226745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection of the central nervous system: clinical features and neuropathogenesis.
    Boissé L; Gill MJ; Power C
    Neurol Clin; 2008 Aug; 26(3):799-819, x. PubMed ID: 18657727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates.
    Goodkin K; Wilkie FL; Concha M; Asthana D; Shapshak P; Douyon R; Fujimura RK; LoPiccolo C
    Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 infection and cognitive impairment in the cART era: a review.
    Schouten J; Cinque P; Gisslen M; Reiss P; Portegies P
    AIDS; 2011 Mar; 25(5):561-75. PubMed ID: 21160410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychological evaluation of the cognitive deficits in infection by human immunodeficiency virus type 1 (HIV-1)].
    Clemente-Millana L; Portellano JA
    Rev Neurol; 2000 Dec 16-31; 31(12):1192-201. PubMed ID: 11205557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dementia complex due to HIV disease and aging].
    Moulignier A
    Psychol Neuropsychiatr Vieil; 2007 Sep; 5(3):193-207. PubMed ID: 17872328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in the hemodynamic response function in cognitively impaired HIV/AIDS subjects.
    Juengst SB; Aizenstein HJ; Figurski J; Lopez OL; Becker JT
    J Neurosci Methods; 2007 Jul; 163(2):208-12. PubMed ID: 17540453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dementia and human inmmunodeficiency virus infection].
    Gray F
    Rev Neurol (Paris); 1998; 154 Suppl 2():S91-8. PubMed ID: 9834549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine.
    Cherner M; Letendre S; Heaton RK; Durelle J; Marquie-Beck J; Gragg B; Grant I;
    Neurology; 2005 Apr; 64(8):1343-7. PubMed ID: 15851720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The HIV Dementia Scale: predictive power in mild dementia and HAART.
    Bottiggi KA; Chang JJ; Schmitt FA; Avison MJ; Mootoor Y; Nath A; Berger JR
    J Neurol Sci; 2007 Sep; 260(1-2):11-5. PubMed ID: 17482212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 associated dementia: symptoms and causes.
    Ghafouri M; Amini S; Khalili K; Sawaya BE
    Retrovirology; 2006 May; 3():28. PubMed ID: 16712719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurobiology of HIV.
    Hult B; Chana G; Masliah E; Everall I
    Int Rev Psychiatry; 2008 Feb; 20(1):3-13. PubMed ID: 18240058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HIV-1 cognitive and motor syndrome].
    Mussa M; Preux PM; Debrock C; Chazot-Balcon M; Melaku Z; Druet-Cabanac M; Kayembe K; Dumas M
    Sante; 1997; 7(3):187-93. PubMed ID: 9296810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS.
    Vivithanaporn P; Nelles K; DeBlock L; Newman SC; Gill MJ; Power C
    J Neurol Sci; 2012 Jan; 312(1-2):45-51. PubMed ID: 21925684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluations in HIV-1-associated cognitive/motor complex.
    Syndulko K; Singer EJ; Nogales-Gaete J; Conrad A; Schmid P; Tourtellotte WW
    Psychiatr Clin North Am; 1994 Mar; 17(1):91-123. PubMed ID: 8190671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and biologic features of the AIDS dementia complex.
    Navia BA
    Neuroimaging Clin N Am; 1997 Aug; 7(3):581-92. PubMed ID: 9376969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies.
    Ances BM; Clifford DB
    Curr Neurol Neurosci Rep; 2008 Nov; 8(6):455-61. PubMed ID: 18957181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1-associated dementia: a basic science and clinical perspective.
    Diesing TS; Swindells S; Gelbard H; Gendelman HE
    AIDS Read; 2002 Aug; 12(8):358-68. PubMed ID: 12229893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
    Schifitto G; Zhang J; Evans SR; Sacktor N; Simpson D; Millar LL; Hung VL; Miller EN; Smith E; Ellis RJ; Valcour V; Singer E; Marra CM; Kolson D; Weihe J; Remmel R; Katzenstein D; Clifford DB;
    Neurology; 2007 Sep; 69(13):1314-21. PubMed ID: 17652642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.